SPDR S&P Biotech ETF $XBI Stock Acquired by Tamar Securities LLC

Tamar Securities LLC boosted its position in SPDR S&P Biotech ETF (NYSEARCA:XBI) by 13.0% in the 3rd quarter, according to its most recent filing with the Securities and Exchange Commission. The fund owned 82,493 shares of the exchange traded fund’s stock after purchasing an additional 9,522 shares during the quarter. Tamar Securities LLC’s holdings in SPDR S&P Biotech ETF were worth $13,008,000 as of its most recent filing with the Securities and Exchange Commission.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Bank of America Corp DE increased its holdings in SPDR S&P Biotech ETF by 13.3% in the 1st quarter. Bank of America Corp DE now owns 14,518,027 shares of the exchange traded fund’s stock valued at $1,854,388,000 after purchasing an additional 1,700,851 shares in the last quarter. Main Street Research LLC lifted its position in SPDR S&P Biotech ETF by 57.4% during the 1st quarter. Main Street Research LLC now owns 567,479 shares of the exchange traded fund’s stock worth $72,484,000 after acquiring an additional 206,953 shares in the last quarter. Northwestern Mutual Wealth Management Co. boosted its holdings in SPDR S&P Biotech ETF by 145.7% in the 2nd quarter. Northwestern Mutual Wealth Management Co. now owns 314,224 shares of the exchange traded fund’s stock worth $49,726,000 after acquiring an additional 186,314 shares during the period. Annex Advisory Services LLC raised its stake in shares of SPDR S&P Biotech ETF by 4.6% during the third quarter. Annex Advisory Services LLC now owns 266,485 shares of the exchange traded fund’s stock valued at $42,019,000 after purchasing an additional 11,723 shares during the period. Finally, Moss Adams Wealth Advisors LLC purchased a new position in shares of SPDR S&P Biotech ETF in the third quarter valued at $30,841,000.

SPDR S&P Biotech ETF Stock Up 2.6%

Shares of SPDR S&P Biotech ETF stock traded up $3.81 on Friday, hitting $152.21. 10,549,785 shares of the company’s stock traded hands, compared to its average volume of 9,198,628. The firm’s 50-day moving average is $155.22 and its 200 day moving average is $142.29. SPDR S&P Biotech ETF has a 52-week low of $106.30 and a 52-week high of $169.89. The stock has a market cap of $10.41 billion, a P/E ratio of 11.47 and a beta of 0.87.

SPDR S&P Biotech ETF Profile

SPDR S&P Biotech ETF (the Fund) seeks to closely match the returns and characteristics of the S&P Biotechnology Select Industry Index. The S&P Biotechnology Select Industry Index represents the biotechnology sub-industry portion of the S&P Total Markets Index. The S&P TMI tracks all the United States common stocks listed on the New York Stock Exchange, American Stock Exchange, National Association of Securities Dealers Automated Quotation (NASDAQ) National Market and NASDAQ Small Cap exchanges. The Biotech Index is a modified equal weight index.